Hatton Research Institutes

Cincinnati, Ohio 45220

0 studies enrolling now · 2 studies all time

What they study most

Glioblastoma

Studies at this site

• A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma — Completed
• A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma — Completed